£2.2M
The funding round was led by Equity Gap with participation from Scottish Enterprise, SIS Ventures and Alba Equity.
SIS Ventures
Venture CapitalSIS Ventures is an impact investor backing businesses with potential for significant social impact.
Recent investments
£5.0M
Par Equity led the Series A round with participation from Mercia, Triplepoint, SIS Ventures, Scottish Enterprise and the MacLeod Family Trust.
"Our technology is already making a significant impact within counter terror and child sexual abuse investigations in the UK, and we're excited to build on this momentum in mainland Europe and the US. We've built a great network of partners to support our ambitious growth plans, and our team will double in size during each of the next two years to support this growth."
£1.2M
Northstar Ventures led the £1.2m round to support the commercial rollout of the medtech firm's diagnostic device.
£2.4M
The funding round was led by Mercia EIS Funds alongside several institutional backers.
£2.4M
The funding round was led by Mercia and will support the firm in progressing its multi-cancer diagnostic programmes.
"Worldwide, 26,000 people die from cancer each day. Early detection is critical for effective treatment, but many cancers go undetected for too long. This funding is another significant step forward for ClinSpec Dx in our mission to detect cancer earlier and help to increase patient survival and quality of life."